Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia

Acute myeloid leukemia (AML) is the most common acute leukemia in adults, with approximately four new cases per 100,000 persons per year. Standard treatment for AML consists of induction chemotherapy with remission achieved in 50 to 75% of cases. Unfortunately, most patients will relapse and die fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Lamble, Adam J., Kosaka, Yoko, Laderas, Ted, Maffit, Allie, Kaempf, Andy, Brady, Lauren K., Wang, Weiwei, Long, Nicola, Saultz, Jennifer N., Mori, Motomi, Soong, David, LeFave, Clare V., Huang, Fei, Adams, Homer, Loriaux, Marc M., Tognon, Cristina E., Lo, Pierrette, Tyner, Jeffrey W., Fan, Guang, McWeeney, Shannon K., Druker, Brian J., Lind, Evan F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2020
Materias:
Biological Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321988/
https://www.ncbi.nlm.nih.gov/pubmed/32513686
http://dx.doi.org/10.1073/pnas.1916206117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321988/
https://www.ncbi.nlm.nih.gov/pubmed/32513686
http://dx.doi.org/10.1073/pnas.1916206117

Ejemplares similares